These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 723351)

  • 41. Dosimetry of cytostatics in hyperthermic regional isolated perfusion.
    van Os J; Schraffordt Koops H; Oldhoff J
    Cancer; 1985 Feb; 55(4):698-701. PubMed ID: 3967166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
    Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
    Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated regional perfusion in malignant melanoma of the extremities.
    Schraffordt Koops H; Oldhoff J; Oosterhuis JW; Beekhuis H
    World J Surg; 1987 Aug; 11(4):527-33. PubMed ID: 3630197
    [No Abstract]   [Full Text] [Related]  

  • 44. [Perfusion of the extremities in malignant melanoma. Indication, technic and results].
    Nagel K; Junginger T
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1626-9. PubMed ID: 3665750
    [No Abstract]   [Full Text] [Related]  

  • 45. Perfusion of melanoma. 105 isolated perfusions in 92 patients.
    Golomb FM
    Oncology; 1972; 26(2):197-205. PubMed ID: 4626136
    [No Abstract]   [Full Text] [Related]  

  • 46. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 47. Hyperthermic perfusion with chemotherapy for melanoma of the extremities.
    Ghussen F; Krüger I; Smalley RV; Groth W
    World J Surg; 1989; 13(5):598-602. PubMed ID: 2815804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of regional limb perfusion with melphalan for malignant melanoma.
    Irvine WT; Luck RJ
    Br Med J; 1966 Mar; 1(5490):770-4. PubMed ID: 5910107
    [No Abstract]   [Full Text] [Related]  

  • 49. Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma.
    Clark J; Grabs AJ; Parsons PG; Smithers BM; Addison RS; Roberts MS
    Melanoma Res; 1994 Dec; 4(6):365-70. PubMed ID: 7703715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
    Lejeune FJ; Mathieu M; Kenis Y
    Tumori; 1977; 63(3):289-98. PubMed ID: 898296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival after regional perfusion for limb melanoma.
    Cox KR
    Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
    Hansson JA; Simert G; Vang J
    Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced melanoma of the extremities.
    McBride CM
    Arch Surg; 1970 Aug; 101(2):122-6. PubMed ID: 5451190
    [No Abstract]   [Full Text] [Related]  

  • 54. Rapid measurement of blood leakage during regional chemotherapy.
    Alexander C; Omlor G; Berberich R; Gross G; Feifel G
    Eur J Nucl Med; 1993 Mar; 20(3):187-91. PubMed ID: 8385020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyperthermic adjuvant perfusion chemotherapy for Stage I malignant melanoma of the extremity with literature review.
    Rege VB; Leone LA; Soderberg CH; Coleman GV; Robidoux HJ; Fijman R; Brown J
    Cancer; 1983 Dec; 52(11):2033-9. PubMed ID: 6354421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.
    Vrouenraets BC; Klaase JM; Kroon BB; van Geel BN; Eggermont AM; Franklin HR
    Arch Surg; 1995 Jan; 130(1):43-7. PubMed ID: 7802575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perfusion in limb melanoma: indications and results.
    Fontaine CJ; Jamieson CW
    Proc R Soc Med; 1974 Feb; 67(2):99-100. PubMed ID: 4821238
    [No Abstract]   [Full Text] [Related]  

  • 58. Multiple cutaneous melanoma metastases of an extremity resembling Kaposi's sarcoma: use of regional perfusion.
    Lancer HA; Bronstein BR; Sober AJ
    J Dermatol Surg Oncol; 1984 Mar; 10(3):196-9. PubMed ID: 6699257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomy.
    Fletcher JR; White CR; Fletcher WS
    Am J Surg; 1986 May; 151(5):593-8. PubMed ID: 3518512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
    Krementz ET; Ryan RF
    Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.